OUR PEOPLE

SIMON KIDDLE

Partner, Patent Attorney
Head of Life Sciences

Bristol

Simon has nearly 30 years’ experience in original patent drafting, patent strategy European oppositions and appeals, including complex multi-party proceedings, and due diligence work, across the life sciences field for both large and small molecule therapeutics. He has worked on the portfolios covering many top selling biologics and has been at the forefront of patenting in the field of precision medicine and life cycle management for therapeutics. Simon heads up the firm’s Life Sciences practice group and is a member of our Management Board.

Areas of Expertise

  • biologics such as antibody, protein and peptide therapeutics
  • tumour necrosis factor receptor and ligand biology
  • small molecule pharmaceutical chemistry
  • industrial bioscience, especially enzyme engineering for various industrial and domestic uses
  • next generation sequencing
  • formulation technology
  • biological nanoparticles and their uses
  • microfluidic devices
  • microarray technology

Clients

Simon works with large and small biotech companies, universities and research charities. He also advises start-up companies and investors in patent strategy.

Background

Simon has a chemistry degree from Oxford University. He joined Mewburn Ellis in 1991, qualifying as a Chartered Patent Attorney in 1994 and a European Patent Attorney the following year. He joined the partnership in 1997.

Recommendations

Frequently listed in Legal 500 and IAM Patent 1000, gaining praise for being “thorough”, “diligent”, “efficient” and “reliable”, Simon has also been recognised for his work as part of a team defending five European patents in a string of EPO proceedings.

Simon “quickly understands the nuances of complex portfolios and provides expert strategic advice” - IAM Patent 1000, 2020

“A cleantech guru, with the ability to craft spotless patents and defend the least promising EPO cases with remarkable success” -  IAM Patent 1000, 2019

Noteable practitioner  - Chambers & Partners, 2019